Profil
Denis Bedoret currently works at ImCyse SA, as Chief Executive Officer & Director from 2020, Exothera SA, as Director, and Ncardia Holding SA, as Director from 2021.
Dr. Bedoret also formerly worked at Orgenesis, Inc., as General Manager-Masthercell, Catalent Gosselies SA, as General Manager from 2017 to 2018, and Catalent MSTC, Inc., as President.
Dr. Bedoret received his undergraduate degree and doctorate degree from the University of Liege.
Aktive Positionen von Denis Bedoret
| Unternehmen | Position | Beginn |
|---|---|---|
ImCyse SA
ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Vorstandsvorsitzender | 01.09.2020 |
Exothera SA
Exothera SA BiotechnologyHealth Technology Manufactures and develops viral vectors & nucleic acids | Direktor/Vorstandsmitglied | 21.09.2020 |
Ncardia Holding SA
Ncardia Holding SA BiotechnologyHealth Technology Provides biotech research and development, business management consulting, technical testing & administrative services | Direktor/Vorstandsmitglied | 11.11.2021 |
Ehemalige bekannte Positionen von Denis Bedoret
| Unternehmen | Position | Ende |
|---|---|---|
| ORGENESIS INC. | Corporate Officer/Principal | - |
Catalent MSTC, Inc.
Catalent MSTC, Inc. Medical SpecialtiesHealth Technology Engages in third party contract manufacturing for cell therapy companies | Präsident | - |
Catalent Gosselies NV
Catalent Gosselies NV BiotechnologyHealth Technology Provides cell therapy manufacturing services | Vorstandsvorsitzender | - |
Ausbildung von Denis Bedoret
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Orgenesis, Inc.
Orgenesis, Inc. Packaged SoftwareTechnology Services Offers POCare services platform for biotech companies and hospitals to supply their products and develops potential of cell and gene therapies | Technology Services |
University of Liege
University of Liege Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Health Technology |
Catalent Gosselies NV
Catalent Gosselies NV BiotechnologyHealth Technology Provides cell therapy manufacturing services | Health Technology |
Catalent MSTC, Inc.
Catalent MSTC, Inc. Medical SpecialtiesHealth Technology Engages in third party contract manufacturing for cell therapy companies | Health Technology |
Exothera SA
Exothera SA BiotechnologyHealth Technology Manufactures and develops viral vectors & nucleic acids | Health Technology |
Ncardia Holding SA
Ncardia Holding SA BiotechnologyHealth Technology Provides biotech research and development, business management consulting, technical testing & administrative services | Health Technology |
















